The clinical significance of antiphospholipid antibodies in COVID-19 infection

• DOI: 10.3855/jidc.15423
• Publication Date: 2022-03-15T21:33:16Z
• Authors: Ebru Atalar; Abdulsamet Erden; Serdar Can Guven; Berkan Armagan; İhsan Ates; Orhan Küçüksahin; Ahmet Omma
• Keywords: Clinical Significance; myalgia

Introduction: One of the factors that may aggravate clinical presentation in COVID-19 is increased level antiphospholipid antibodies (aPLs) and thrombotic events can be seen with disease. In our retrospective study, we aimed to evaluate effect aPLs on findings patients a diagnosis COVID-19.
 Methodology: Seventy-three diagnosed examined for were included study. Patients divided into two groups according test results aPLs. Clinical laboratory parameters compared both reveal whether there was any difference between groups.
 Results: There 15 positive test. Dyspnea, nausea, vomiting, myalgia, abdominal pain significantly higher group than those negative The duration hospital stays need oxygen therapy group. However, no found terms mechanical ventilation need, intensive care admission rate, thrombosis mortality. findings, have median C-reactive protein (CRP) ferritin values aPLs.
 Conclusions: study group, could not find relationship positivity critical complications. According hypothesis, it necessary routinely examine determine risk thromboembolic